MicroVision (NASDAQ: MVIS) director acquires 28,185 shares in subscription deal

Rhea-AI Filing Summary

MicroVision director Jada Smith acquired 28,185 shares of common stock directly from the company in a subscription transaction. The shares were purchased at $0.5322 per share, matching the closing price of MicroVision stock on March 13, 2026.

After this grant/award acquisition, Smith directly owns 154,543 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions with the issuer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Jada

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		A(2)		28,185	A	$0.5322	154,543	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 28,185 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.

2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

	/s/ Drew G. Markham, attorney-in-fact for Jada Smith	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MicroVision (MVIS) director Jada Smith report?

Jada Smith reported acquiring 28,185 shares of MicroVision common stock directly from the company. The transaction was structured as a subscription with the issuer and is intended to qualify as an exempt transaction under Rule 16b-3 governing certain insider dealings.

At what price did Jada Smith acquire new MicroVision (MVIS) shares?

Smith acquired 28,185 MicroVision shares at $0.5322 per share. This price was equal to the closing price of MicroVision’s common stock on March 13, 2026, and reflects a direct purchase from the company rather than an open-market trade.

How many MicroVision (MVIS) shares does Jada Smith hold after this Form 4 transaction?

Following the reported acquisition, Jada Smith directly holds 154,543 shares of MicroVision common stock. This total includes the newly acquired 28,185 shares obtained through the subscription agreement executed with the company on March 15, 2026.

Was Jada Smith’s MicroVision (MVIS) share purchase an exempt insider transaction?

Yes. The company states the purchase is intended to be an exempt transaction under Rule 16b-3. This rule covers certain insider transactions with the issuer, such as director purchases directly from the company under approved arrangements.

Did Jada Smith buy MicroVision (MVIS) shares on the open market?

No. Smith acquired the 28,185 shares directly from MicroVision under a subscription agreement. The shares were purchased at $0.5322 per share, equal to the stock’s March 13, 2026 closing price, rather than through open-market trading.